Baker Bros. Advisors Boosts Stake in Vanda Pharmaceuticals Inc. (VNDA)

Page 2 of 2

XOMA Corp (NASDAQ:XOMA) is represented in the equity portfolio of Baker Bros. by a $70.6 million stake, which contains 20.3 million shares. In ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), the hedge fund owns about 15.6 million shares, valued at $124 million. Genomic Health, Inc. (NASDAQ:GHDX), Bakers’ fund holds almost 12.6 million shares, worth $355.7 million.

With this in mind, we’ll keep you on the loop about all the moves surrounding Vanda Pharmaceuticals Inc. (NASDAQ:VNDA).

Page 2 of 2